Maternal blood to
screen the most common fetal chromosome abnormalities
Details
Description
Test Code: MGM1842
NIPT is a safe, simple,
non-invasive prenatal test, which offers screening for certain genetic
conditions from as early as week 9 of pregnancy. Using the latest genetic
sequencing technology, Panorama is the most advanced Non-Invasive Prenatal Test
(NIPT) performed on maternal blood to screen the most common fetal chromosome
abnormalities such as t21, t18, t13, Monosomy X, Triploidy and Microdeletions.
The test can be used as early as 9
weeks of gestation.(Valid Between 10-24 weeks of gestation)
The Test is done by using Maternal Peripheral Blood.
The test is accurate even at fetal
fractions as low as 4%.
Only NIPT test that uses
SNPs(Single Nucleotide Polymorphisms) to differentiate maternal from the fetal
DNA.
Sensitivity & Specificity
>99%
Recommended for whom?
Women who wish to have
non-invasive fetal aneuploides test for Trisomy 21,18 and 13.
Women whose age is 35 or above and
do not choose to receive invasive prenatal tests.
Women who receive IVF or
previously suffered from habitual abortion.
Specimen
8-10ml of maternal blood. These are to collected in special kit
provided by Nita Labs.
Follow sample collection process as mentioned in KIT. After sample collection rotate the streck tube 10 times clockwise and 10 times anti clockwise (Please send duly filled , signed and stamped PNDT (Pre-Natal Diagnostic Test Form G)
Free Home/Office Sample Collection. Call or WhatsApp 9801036380/9801831090
Reported on
14 working days
Precaution
Specimen
These are to collected in special kit provided by Nita Labs.